World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
77
Citations
29415
World Ranking
18280
National Ranking
1661

Tessa L. Holyoake publication distribution in Medicine in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Medicine in 2026. The highlighted bar marks where Tessa L. Holyoake sits on this spectrum.

101–120 publications: 5 scientists 121–140 publications: 26 scientists 141–160 publications: 73 scientists 161–180 publications: 155 scientists 181–200 publications: 230 scientists 201–220 publications: 363 scientists 221–240 publications: 487 scientists 241–260 publications: 545 scientists 261–280 publications: 722 scientists 281–300 publications: 768 scientists 301–320 publications: 834 scientists 321–340 publications: 895 scientists 341–360 publications: 922 scientists 361–380 publications: 838 scientists 381–400 publications: 861 scientists 401–420 publications: 918 scientists 421–440 publications: 806 scientists 441–460 publications: 771 scientists 461–480 publications: 751 scientists 481–500 publications: 713 scientists 501–520 publications: 617 scientists 521–540 publications: 611 scientists 541–560 publications: 537 scientists 561–580 publications: 504 scientists 581–600 publications: 509 scientists 601–620 publications: 396 scientists 621–640 publications: 386 scientists 641–660 publications: 371 scientists 661–680 publications: 340 scientists 681–700 publications: 336 scientists 701–720 publications: 307 scientists 721–740 publications: 259 scientists 741–760 publications: 230 scientists 761–780 publications: 228 scientists 781–800 publications: 217 scientists 801–820 publications: 204 scientists 821–840 publications: 186 scientists 841–860 publications: 177 scientists 861–880 publications: 155 scientists 881–900 publications: 139 scientists 901–920 publications: 145 scientists 921–940 publications: 116 scientists 941–960 publications: 133 scientists 961–980 publications: 91 scientists 981–1,000 publications: 96 scientists 1,001–1,020 publications: 77 scientists 1,021–1,040 publications: 70 scientists 1,041–1,060 publications: 63 scientists 1,061–1,080 publications: 77 scientists 1,081–1,100 publications: 49 scientists 1,101–1,120 publications: 54 scientists 1,121–1,140 publications: 49 scientists 1,141–1,160 publications: 51 scientists 1,161–1,180 publications: 35 scientists 1,181–1,200 publications: 39 scientists 1,201–1,220 publications: 26 scientists 1,221–1,240 publications: 37 scientists 1,241–1,260 publications: 36 scientists 1,261–1,280 publications: 27 scientists 1,281–1,300 publications: 32 scientists 1,301–1,320 publications: 28 scientists 1,321–1,340 publications: 17 scientists 1,341–1,360 publications: 30 scientists 1,361–1,380 publications: 28 scientists 1,381–1,400 publications: 17 scientists 1,401–1,420 publications: 21 scientists 1,421–1,440 publications: 15 scientists 1,441–1,460 publications: 12 scientists 1,461–1,480 publications: 12 scientists 1,481–1,500 publications: 18 scientists 1,501–1,520 publications: 14 scientists 1,521–1,540 publications: 17 scientists 1,541–1,560 publications: 15 scientists 1,561–1,580 publications: 6 scientists 1,581–1,600 publications: 2 scientists 1,601–1,620 publications: 12 scientists 1,621–1,640 publications: 11 scientists 1,641–1,660 publications: 8 scientists 1,661–1,680 publications: 5 scientists 1,681–1,700 publications: 5 scientists 1,701–1,720 publications: 10 scientists 1,721–1,740 publications: 12 scientists 1,741–1,760 publications: 14 scientists 1,761–1,780 publications: 6 scientists 1,781–1,795 publications: 5 scientists 1,796+ publications: 100 scientists
101 publications 1,796+

This scientist: 377 publications — 33rd percentile

33% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,796 publications or more.

Tessa L. Holyoake D-index placement in Medicine in 2026

The chart shows the D-index (discipline H-index) distribution of Medicine scientists ranked by Research.com in 2026. The highlighted bar marks where Tessa L. Holyoake sits on this spectrum.

70–71 D-Index: 226 scientists 72–73 D-Index: 391 scientists 74–75 D-Index: 574 scientists 76–77 D-Index: 730 scientists 78–79 D-Index: 891 scientists 80–81 D-Index: 972 scientists 82–83 D-Index: 1,027 scientists 84–85 D-Index: 1,003 scientists 86–87 D-Index: 960 scientists 88–89 D-Index: 970 scientists 90–91 D-Index: 922 scientists 92–93 D-Index: 839 scientists 94–95 D-Index: 808 scientists 96–97 D-Index: 779 scientists 98–99 D-Index: 668 scientists 100–101 D-Index: 611 scientists 102–103 D-Index: 630 scientists 104–105 D-Index: 513 scientists 106–107 D-Index: 541 scientists 108–109 D-Index: 445 scientists 110–111 D-Index: 429 scientists 112–113 D-Index: 400 scientists 114–115 D-Index: 393 scientists 116–117 D-Index: 318 scientists 118–119 D-Index: 302 scientists 120–121 D-Index: 287 scientists 122–123 D-Index: 255 scientists 124–125 D-Index: 256 scientists 126–127 D-Index: 252 scientists 128–129 D-Index: 230 scientists 130–131 D-Index: 179 scientists 132–133 D-Index: 168 scientists 134–135 D-Index: 163 scientists 136–137 D-Index: 159 scientists 138–139 D-Index: 134 scientists 140–141 D-Index: 134 scientists 142–143 D-Index: 118 scientists 144–145 D-Index: 109 scientists 146–147 D-Index: 106 scientists 148–149 D-Index: 74 scientists 150–151 D-Index: 79 scientists 152–153 D-Index: 80 scientists 154–155 D-Index: 87 scientists 156–157 D-Index: 57 scientists 158–159 D-Index: 74 scientists 160–161 D-Index: 69 scientists 162–163 D-Index: 60 scientists 164–165 D-Index: 53 scientists 166–167 D-Index: 39 scientists 168–169 D-Index: 42 scientists 170–171 D-Index: 32 scientists 172–173 D-Index: 39 scientists 174–175 D-Index: 40 scientists 176–177 D-Index: 28 scientists 178–179 D-Index: 19 scientists 180–181 D-Index: 23 scientists 182–183 D-Index: 31 scientists 184–185 D-Index: 18 scientists 186–187 D-Index: 20 scientists 188–189 D-Index: 22 scientists 190–191 D-Index: 13 scientists 192–193 D-Index: 21 scientists 194–195 D-Index: 12 scientists 196–197 D-Index: 12 scientists 198–199 D-Index: 14 scientists 200–201 D-Index: 15 scientists 202–203 D-Index: 13 scientists 204–205 D-Index: 10 scientists 206–207 D-Index: 8 scientists 208–209 D-Index: 4 scientists 210–211 D-Index: 12 scientists 212–213 D-Index: 11 scientists 214–215 D-Index: 10 scientists 216 D-Index: 4 scientists 217+ D-Index: 98 scientists
70 D-Index 217+

This scientist: 77 D-Index — 10th percentile

10% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 217 D-Index or more.

Overview

Tessa L. Holyoake was affiliated with the University of Glasgow in the United Kingdom. Their research primarily focused on the fields of Medicine and Biochemistry, Genetics and Molecular Biology, with a strong emphasis on subfields such as Hematology, Molecular Biology, Genetics, Oncology, and Pathology and Forensic Medicine.

The scientist's body of work covered topics including:

  • Chronic Myeloid Leukemia Treatments
  • Chronic Lymphocytic Leukemia Research
  • Protein Degradation and Inhibitors
  • Multiple Myeloma Research and Treatments
  • Ubiquitin and proteasome pathways
  • HER2/EGFR in Cancer Research
  • Histone Deacetylase Inhibitors Research

Among the frequent coauthors with whom Holyoake collaborated were:

  • Mhairi Copland
  • Richard E. Clark
  • Anne-Louise Latif
  • Ashley Newcombe
  • Neil Robertson

The scientist published extensively in a select group of venues, including:

  • Leukemia
  • bioRxiv (Cold Spring Harbor Laboratory)
  • Nature Communications
  • Cancer Cell
  • Blood

Recent papers by Tessa L. Holyoake include:

  • A randomised phase II trial of hydroxychloroquine and imatinib versus imatinib alone for patients with chronic myeloid leukaemia in major cytogenetic response with residual disease, 2020, Leukemia
  • BRD4-mediated repression of p53 is a target for combination therapy in AML, 2021, Nature Communications
  • CD93 is expressed on chronic myeloid leukemia stem cells and identifies a quiescent population which persists after tyrosine kinase inhibitor therapy, 2020, Leukemia
  • BRD4-mediated repression of p53 is a target for combination therapy in AML, 2020, bioRxiv (Cold Spring Harbor Laboratory)
  • Loss or Inhibition of Stromal-Derived PlGF Prolongs Survival of Mice with Imatinib-Resistant Bcr-Abl1+ Leukemia, 2020, Cancer Cell

Best Publications

  • Guidelines for the use and interpretation of assays for monitoring autophagy

    Daniel J. Klionsky;Fabio C. Abdalla;Hagai Abeliovich;Robert T. Abraham

  • Primitive, quiescent, Philadelphia-positive stem cells from patients with chronic myeloid leukemia are insensitive to STI571 in vitro

    Susan M. Graham;Heather G. Jørgensen;Elaine Allan;Charlie Pearson

  • Dasatinib (BMS-354825) targets an earlier progenitor population than imatinib in primary CML but does not eliminate the quiescent fraction

    Mhairi Copland;Ashley Hamilton;Lucy J. Elrick;Janet W. Baird

  • The price of drugs for chronic myeloid leukemia (CML) is a reflection of the unsustainable prices of cancer drugs: from the perspective of a large group of CML experts

    Camille Abboud;Ellin Berman;Adam Cohen

  • Targeting autophagy potentiates tyrosine kinase inhibitor-induced cell death in Philadelphia chromosome-positive cells, including primary CML stem cells.

    Cristian Bellodi;Maria Rosa Lidonnici;Ashley Hamilton;G. Vignir Helgason

  • Isolation of a highly quiescent subpopulation of primitive leukemic cells in chronic myeloid leukemia.

    Tessa Holyoake;Xiaoyan Jiang;Connie Eaves;Allen Eaves

  • Chronic myeloid leukemia stem cells are not dependent on Bcr-Abl kinase activity for their survival

    Ashley Hamilton;G. Vignir Helgason;Mirle Schemionek;Bin Zhang

  • Activation of p53 by SIRT1 inhibition enhances elimination of CML leukemia stem cells in combination with imatinib

    Ling Li;Lisheng Wang;Liang Li;Zhiqiang Wang

  • Targeting mitochondrial oxidative phosphorylation eradicates therapy-resistant chronic myeloid leukemia stem cells

    Elodie M Kuntz;Pablo Baquero;Alison M Michie;Karen Dunn

  • Altered Microenvironmental Regulation of Leukemic and Normal Stem Cells in Chronic Myelogenous Leukemia

    Bin Zhang;Yin Wei Ho;Qin Huang;Takahiro Maeda

  • Nilotinib exerts equipotent antiproliferative effects to imatinib and does not induce apoptosis in CD34+ CML cells.

    Heather G. Jørgensen;Elaine K. Allan;Elaine K. Allan;Niove E. Jordanides;Joanne C. Mountford;Joanne C. Mountford

  • Effective Targeting of Quiescent Chronic Myelogenous Leukemia Stem Cells by Histone Deacetylase Inhibitors in Combination with Imatinib Mesylate

    Bin Zhang;Adam C. Strauss;Su Chu;Min Li

  • Autocrine production and action of IL-3 and granulocyte colony-stimulating factor in chronic myeloid leukemia

    Xiaoyan Jiang;Angel Lopez;Tessa Holyoake;Allen Eaves

  • Microenvironmental protection of CML stem and progenitor cells from tyrosine kinase inhibitors through N-cadherin and Wnt–β-catenin signaling

    Bin Zhang;Min Li;Tinisha McDonald;Tessa L. Holyoake

  • The chronic myeloid leukemia stem cell: stemming the tide of persistence.

    Tessa L. Holyoake;David Vetrie

  • Functional differences between transplantable human hematopoietic stem cells from fetal liver, cord blood, and adult marrow.

    Tessa L Holyoake;Franck E Nicolini;Connie J Eaves

  • Prognostic implications of differences in telomere length between normal and malignant cells from patients with chronic myeloid leukemia measured by flow cytometry

    Tim H. Brümmendorf;Tessa L. Holyoake;Nathalie Rufer;Michael J. Barnett

  • PP2A-activating drugs selectively eradicate TKI-resistant chronic myeloid leukemic stem cells

    Paolo Neviani;Jason G. Harb;Joshua J. Oaks;Ramasamy Santhanam

  • Previously undetected human hematopoietic cell populations with short-term repopulating activity selectively engraft NOD/SCID-β2 microglobulin–null mice

    H. Glimm;W. Eisterer;K. Lee;J. Cashman

  • Targeting autophagy potentiates tyrosine kinase inhibitor-induced cell death in Philadelphia chromosome-positive cells, including primary CML stem cells (vol 119, pg 1109, 2009)

    C Bellodi;Lidonnici;A Hamilton;GV Helgason

Frequent Co-Authors

Ravi Bhatia
Ravi Bhatia University of Alabama at Birmingham
Connie J. Eaves
Connie J. Eaves University of British Columbia
Xiaoyan Jiang
Xiaoyan Jiang University of British Columbia
Bruno Calabretta
Bruno Calabretta Thomas Jefferson University
Anthony D. Whetton
Anthony D. Whetton University of Manchester
Tim H. Brümmendorf
Tim H. Brümmendorf RWTH Aachen University
Allen C. Eaves
Allen C. Eaves Stemcell Technologies
John M. Goldman
John M. Goldman Imperial College London
Andreas Hochhaus
Andreas Hochhaus Friedrich Schiller University Jena
Jane F. Apperley
Jane F. Apperley Imperial College London

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

If you're considering a career in medicine but want flexible options, there are a variety of related online degrees and alternative career paths to explore. Many students start their journey in healthcare by pursuing nursing. For those looking to bypass entrance exams, there are nursing schools that don't require teas or hesi, making it easier to get started.

Another popular choice is healthcare management. Earning an online degree from one of the healthcare administration degree programs can open doors to leadership roles in hospitals, clinics, and health organizations.

For nurses seeking advanced practice roles, there are asn to nurse practitioner programs available online. These bridge programs allow registered nurses to accelerate their education and expand their scope of practice.

Nutrition is another growing field within healthcare. Consider pursuing an online degree from one of the best online food science degree programs to enter careers in wellness, public health, or the food industry.

Each of these educational paths offers unique opportunities and flexible study options for aspiring healthcare professionals.

Best Scientists Citing Tessa L. Holyoake

Recently Published Articles